Search

everythinglearnresearchcommunity

for

Search:↓

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Refractory alopecia areata can be managed with medical treatments, psychological support, and aesthetic options.

Alopecia causes sudden hair loss, possibly due to genetic, environmental, or immune factors.

Consider Castleman's disease in similar cases; histology and steroids help diagnose and manage it.

Moth-eaten alopecia is linked to various skin diseases and requires early treatment to prevent worsening.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

The document explains how to claim CME credit by diagnosing and treating hair loss conditions in two patient cases.

Control symptoms and use safe treatments for skin conditions like lichen planopilaris and chronic cutaneous lupus erythematosus.

Surgery may be needed for resistant thyrotoxicosis.

Collagen XVII is important for cell functions and its absence can worsen cancer outcomes.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Female pattern hair loss is caused by genetics and hormones, leading to hair thinning in women.

Oral minipulse therapy with betamethasone effectively promotes hair regrowth in alopecia areata with fewer side effects.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Androgenetic alopecia is common hair loss due to genetics and hormones, manageable with early treatment.

Some hair growth cells remain in partially bald areas of Indian men with hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

The document concludes that pediatricians play a vital role in supporting adolescents through puberty and should enhance their competence in this area.

Deleting MED1 in skin cells causes hair loss and skin changes.

ALDOA levels drop in hair cells during hair loss.

β1 integrin may indicate and influence the severity of hair loss in androgenetic alopecia.